|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.18 EUR | -0.81% |
|
-2.57% | +1.55% |
| 01:16pm | Sanofi to invest $437 million in India global centre, double its workforce | RE |
| 10:20am | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
PARIS (Reuters) - French healthcare company Sanofi said on Wednesday that it expected its fourth quarter results, which will be published early next month, to reflect a boost from foreign exchange movements and from flu vaccine sales.
Sanofi conducts much of its business in the United States and since it reports results in terms of the euro currency, it would benefit from the strength of the U.S. dollar against the euro.
Sanofi said its preliminary estimate of currency movements were for a boost of between 4.5%-5.5% on Q4 sales and a positive impact of between 6%-7% on its fourth quarter core earnings per share.
(Reporting by Sudip Kar-Gupta; Editing by Christian Schmollinger)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 91.17 EUR | -0.82% | -2.57% | 125B | ||
| 1.303 USD | +0.43% | +1.31% | - | ||
| 1.191 EUR | +0.03% | +0.37% | - | ||
| 1.094 USD | +0.39% | +0.95% | - | ||
| 0.9143 EUR | -0.33% | -0.94% | - | ||
| 0.7312 USD | +0.03% | -0.45% | - | ||
| 0.6741 USD | +0.14% | -0.27% | - | ||
| 0.6686 EUR | -0.35% | -1.37% | - | ||
| 0.6157 EUR | -0.27% | -1.19% | - | ||
| 0.6081 USD | +0.18% | -0.11% | - | ||
| 0.012 USD | +0.02% | 0.00% | - | ||
| 0.0109 EUR | -0.35% | -1.80% | - | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +1.55% | 125B | |
| +61.53% | 848B | |
| +33.32% | 627B | |
| -3.66% | 363B | |
| +15.06% | 318B | |
| +9.18% | 299B | |
| +13.64% | 243B | |
| +16.05% | 225B | |
| +15.67% | 179B | |
| +2.47% | 167B |
SANOFI 
